Ysios Capital, specializing in biotech investments, will invest $157 million in Engrail Therapeutics, joining a syndicate led by F-Prime Capital. Engrail, founded in 2019, focuses on...
In a year marked by the COVID-19 pandemic, the venture capital manager Ysios Capital carried out six follow-on operations and made five new investments, two in...
SparingVision has recently closed a financing round during which it managed to raise $52.7 million (€44.5 million). The resources will enable the company to advance the...